Elevance Health price target raised to $450 from $400 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Elevance Health to $450 from $400 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells in